Note that some links may require registration or subscription.
The COVID-19 antiviral molnupiravir (Lagevrio) was linked with new mutations of the virus. (Nature)
Spending opioid settlement money to curb youth addiction can be complicated. (KFF Health News)
Some pediatric chemotherapy drugs have critical shortages, oncologists said. (NBC News)
The Pfizer plant heavily damaged during a tornado in July restarted production. (Associated Press)
More than 75,000 health workers plan to strike next month if Kaiser Permanente and union representatives can’t negotiate a labor deal. (KFF Health News)
Costco is offering virtual primary care for $29. (CBS News)
A Florida man pleaded guilty to distributing more than $16 million of adulterated HIV drugs that were dispensed around the country, the Department of Justice said.
Pakistan is investigating two local distributors of the cancer drug bevacizumab (Avastin) after 12 diabetic patients who used the drug went blind. (Reuters)
Meanwhile, the FDA is cracking down on companies for failing to prove sufficient testing of ingredients in over-the-counter medications after deaths from contaminated cough syrup overseas. (Reuters)
In 2022, New York City saw the highest number of overdose deaths (3,026) since the city started recording such data in 2000. (ABC News)
The number of New York Fire Department employees who died from World Trade Center-related illnesses is now the same as the number of employees who died at ground zero on September 11, 2001. (NPR)
Former President Donald Trump reportedly stopped masking during the early days of the COVID-19 pandemic because it affected his bronzer, according to a former White House aide. (The Daily News)
The White House said a government shutdown could cut nutritional assistance to nearly 7 million pregnant women, nursing mothers, and children. (The Independent)
Emergency medicine chair Yves Duroseau, MD, MPH, of Lenox Hill Hospital in New York City, and his wife sued after their neighbor allegedly used a hose to end the couple’s dinner party last September. (New York Post)
A CDC official said the agency rolled out the “Wild to Mild” flu vaccine campaign to “reset expectations” about the benefits of the vaccine. (CBS News)
Scynexis recalled the antifungal drug ibrexafungerp (Brexafemme) due to risk of cross-contamination with a possible allergy-inducing compound. (Fierce Pharma)
The FDA approved a liquid oral form of metronidazole (Likmez), Appili Therapeutics said.
Almost one in five online cannabis dispensaries required no formal age verification at any stage of the purchasing process. (JAMA Pediatrics)
-
Michael DePeau-Wilson is a reporter on MedPage Today’s enterprise & investigative team. He covers psychiatry, long covid, and infectious diseases, among other relevant U.S. clinical news. Follow
Please enable JavaScript to view the